Plaza Capital Invests in Spring Loaded to Accelerate Global Expansion of Innovative Orthopedic Bracing
Halifax, Nova Scotia--(Newsfile Corp. - June 17, 2026) - Spring Loaded Technology Inc., a Canadian medical technology company pioneering novel orthopedic bracing and mobility solutions, today announced a strategic investment from Plaza Capital to support the company's next phase of growth, including international expansion, research and development, and continued advancement of evidence-based mobility solutions. The investment follows Spring Loaded's successful management-led buyout com
2026-06-17 7:00 AM EDT | Spring Loaded Technology
WELL Health Announces Voting Results for Election of Directors
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that at its annual general and special meeting held June 16, 2026 (the "Meeting"), all of the nominees for election as directors of the Compa
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-06-17 7:00 AM EDT | WELL Health Technologies Corp.
Defence Therapeutics to Participate in Bio International Convention 2026 Next Week for Strategic Partnership Discussions
Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce its participation in the BIO International Convention 2026, taking place June 22-25 in San Diego, California. Defence's team will be available throughout the conference to meet with pharmaceutical and biotechnology companies, investors, an
Biotechnologies, Pharmaceutique, Santé
2026-06-17 3:15 AM EDT | Defence Therapeutics Inc.
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call
Ontario and Chicago, Illinois--(Newsfile Corp. - June 16, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Friday, June 26, 2026 to discuss Medexus's results for its fourth fiscal quarter and fiscal year ended March 31, 2026. Medexus expects to file its financial statements and MD&A after markets close on June 25, 2026. To participate in the call, please dial the following numbers:
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-16 5:30 PM EDT | Medexus Pharmaceuticals Inc.
Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training
Winter Park, Florida--(Newsfile Corp. - June 16, 2026) - Adia Med, the regenerative medicine and advanced IV therapy division of Adia Nutrition Inc. (OTCQB: ADIA), today announced a major step forward in patient care quality. Renowned physician Dr. Brian Browning, DO, Lead Physician at Adia Med, will personally train the company's Advanced Practice Registered Nurses (APRNs) and Registered Nurses (RNs) in ultrasound-guided intravenous (IV) insertions and administrations using the innovative Bu
Soins de santé et hôpitaux, Santé
2026-06-16 10:55 AM EDT | Adia Nutrition Inc.
TelyRx Announces Voting Results from Annual General Meeting of Shareholders
Clearwater, Florida--(Newsfile Corp. - June 15, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, announced today that each of the following nominees proposed to be elected at the Annual Meeting of Shareholders held on Monday, June 15, 2026 (the "Meeting"), has been elected. In addition, the other resolution put to vote at the Meeting was passed.
Soins de santé et hôpitaux, Santé
2026-06-15 6:57 PM EDT | TelyRx
Functional Brands Inc. Receives Nasdaq Staff Delisting Determination
Lake Oswego, Oregon--(Newsfile Corp. - June 15, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, announced today that on June 9, 2026, it received a written notification (the "Staff Determination") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that Nasdaq has determined to delist the Company's common stock from The Nasdaq Capital Market. As previously disclosed, on D
Produits ménagers / de consommation / cosmétiques, Santé
2026-06-15 8:00 AM EDT | Functional Brands Inc.
Extendicare Announces June 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - June 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare i
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-15 8:00 AM EDT | Extendicare Inc.
CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research
Houston, Texas--(Newsfile Corp. - June 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading under the ticker symbol CBIH, today announced a new chapter in its PTSD-focused research journey, marked by the completion of its patent-related work and the continued exploration of the scientific relationship between cannabinoids and psilocybin in relation to trauma, memory, emotional regulation, and recovery. PTSD affects veterans, first responde
Biotechnologies, Pharmaceutique, Cannabis, Santé
2026-06-15 7:00 AM EDT | Cannabis Bioscience International Holdings
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Northvale, New Jersey--(Newsfile Corp. - June 15, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today reported positive results from a pivotal bioequivalence study for an undisclosed anticonvulsant generic drug product. IQVIA reported branded and generic product sales for the twelve months ending April 2026 of $840 million.
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-06-15 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Cosmo Welcomes the Launches of Winlevi(R) in Austria and Germany
Ireland and Heppenheim, Germany--(Newsfile Corp. - June 15, 2026) - Cosmo N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce the launch of its innovative acne cream Winlevi® (clascoterone 1% cream) in Austria and Germany by its commercial partner InfectoPharm Arzneimittel und Consilium GmbH (“InfectoPharm”). Winlevi® is available in both countries since June 1. Cosmo is the exclusive manufacturer of the product.
Soins de santé et hôpitaux, Santé
2026-06-15 1:01 AM EDT | Cosmo Pharmaceuticals N.V.
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - June 12, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated May 12, 2026 and April 22, 2026, it has closed a second tranche (the "Second Tranche") of its previously announced non-brokered private placement (the "Offering"), which Second Tranche consisted of the issuance of 9,800,000 units
Biotechnologies, Pharmaceutique, Santé
2026-06-12 5:39 PM EDT | PreveCeutical Medical Inc.
Senior Care Authority Releases Father's Day Guide with 10 Warning Signs that Aging Parents Need Support
Incline Village, Nevada--(Newsfile Corp. - June 12, 2026) - Senior Care Authority shares insights on Father’s Day visits, highlighting how the occasion can help families notice when aging parents may be struggling in ways not visible from a distance. "Holiday visits are often when families first notice something has changed," said Frank Samson, founder and CEO of Senior Care Authority. "It's not always dramatic. Sometimes it's a messy kitchen or a conversation that feels sli
Soins de santé et hôpitaux, Santé
2026-06-12 9:00 AM EDT | Senior Care Authority
Akanda Corp. Regains Compliance with Nasdaq Periodic Filing Requirement
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that on June 10, 2026, it received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the "SEC")
Cannabis, Santé, Cultivateurs de cannabis, Producteurs de cannabis
2026-06-12 8:00 AM EDT | Akanda Corp
Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is pleased to announce the results of its annual general and special meeting of shareholders held on May 25, 2026 (the "Meeting"), including shareholder approval of the acquisition by Neural of the remaining 69.25% equity interest in CWE European Holdings Inc. ("CWE") not already owned by the Company, through a series of ancillary transa
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-06-12 7:30 AM EDT | Neural Therapeutics Inc.
Britannia Life Sciences Announces $5.3 Million Acquisition of Commercial Equipment Loan Portfolio
Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Britannia Life Sciences Inc. (CSE: BLAB) (the "Company" or "Britannia") is pleased to announce that it has completed a strategic investment of approximately $5.3 million in a portfolio of performing commercial equipment loans (the "Investment") on highly opportunistic terms. The Investment represents the continued execution of the Company's asset-backed lending strategy and meaningfully expands the Company's base of recurring, high-return c
Biotechnologies, Produits ménagers / de consommation / cosmétiques, Santé, Fournisseurs de services auxiliaires liés au cannabis
2026-06-12 7:30 AM EDT | Britannia Life Sciences Inc
WELL Health Provides a Corporate Update on Circle Medical
WELL Health is providing a corporate update on its majority-owned subsidiary Circle Medical, a leading telehealth platform delivering accessible, insurance-based primary care across the United States. Circle Medical continues to expand access to care, having more than tripled the number of commercially insured patients eligible to receive care on its platform over the last year, supported by strong double-digit growth in new patient bookings and activations in May 2026 as compare
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-06-12 7:00 AM EDT | WELL Health Technologies Corp.
Cheelcare Announces a Non-Brokered Private Placement to Raise up to $1.5 Million
Markham, Ontario--(Newsfile Corp. - June 11, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, announces a non-brokered private placement for the issuance of up to 1,000,000 units of the Company (the "Units") at a price of $1.50 per Unit for aggregate gross proceeds of up to $1,500,000 (the "Offering"). Each Unit consists of one common share in the capital of the Company (a "Share") and one-half of one
2026-06-11 4:30 PM EDT | Cheelcare Inc.
Edison Issues Report on SCHMID (SHMD)
London, United Kingdom--(Newsfile Corp. - June 11, 2026) - Edison issues report on SCHMID (NASDAQ: SHMD). SCHMID is a designer and manufacturer of equipment used in the electronics industry for printed circuit board (PCB) and advanced packaging manufacturing. Focused on the higher end of the sector where advances in packaging are driving demand for new processes and materials, SCHMID has developed cutting-edge tools and patented processes. After a couple of years of weaker demand, manag
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-06-11 11:43 AM EDT | Edison Group
Tersis Technologies and Pingkas Capital Sign MOU to Deploy Syngenic V3 Waste-to-Energy Platform in the Philippines
Brooksville, Florida--(Newsfile Corp. - June 11, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis"), a developer of advanced waste-to-energy and circular-economy technologies, today announced that it has signed a Memorandum of Understanding (MOU) with JL Equities Cap, LLC, doing business as Pingkas Capital ("Pingkas"), to jointly develop, finance, deploy, and operate waste-to-energy projects in the Republic of the Philippines using the Tersis Syngenic V3 technology platform.
Agriculture, Énergie, Énergies de substitution, Santé
2026-06-11 10:13 AM EDT | Tersis Technologies Inc.